Agree Sparky, the benefits of good patient management are clear - market caps of peers that are being patient and waiting for the optimal funding solution are way higher (TON $50m, WKT $110m etc). BAT has a market cap of $28m and has spent more than that on their projects in the last 2 years. DFs ‘progress at all costs’ strategy definitely goes down in the play book as what not to do
Agree Sparky, the benefits of good patient management are clear...
Add WTM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $19.73M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.5¢ | $168.5K | 1.578M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 133171 | 3 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
11.0¢ |
Change
0.005 ( 4.76 %) |
||||
| Open | High | Low | Volume | ||
| 10.5¢ | 12.0¢ | 10.5¢ | 180595 | ||
| Last updated 15.39pm 17/06/2024 ? | |||||
| WTM (ASX) Chart |
